These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 18083387)
1. Prevention of hepatitis C in Japan: a lesson for us all. Heneghan C; Perera R Lancet; 2007 Dec; 370(9604):1982-3. PubMed ID: 18083387 [No Abstract] [Full Text] [Related]
2. [Follow-up study on post-transfusion hepatitis in the Kyushu University Hospital]. Inaba S Fukuoka Igaku Zasshi; 1993 Oct; 84(10):421-6. PubMed ID: 8225154 [No Abstract] [Full Text] [Related]
3. Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan. Yasunaga H Lancet; 2007 Dec; 370(9604):2063-7. PubMed ID: 18083405 [TBL] [Abstract][Full Text] [Related]
4. [Prevention for hepatitis C virus transmission]. Sekiguchi S Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974 [No Abstract] [Full Text] [Related]
5. Japan compensates some of its hepatitis C victims. McCurry J Lancet; 2008 Mar; 371(9618):1061-2. PubMed ID: 18380033 [No Abstract] [Full Text] [Related]
6. [Prevention of post-transfusional hepatitis]. Hernández JM Sangre (Barc); 1988 Jun; 33(3):242. PubMed ID: 3140399 [No Abstract] [Full Text] [Related]
7. National strategy for the prevention and management of transfusion-associated hepatitis. Voigt MD; Bird AR; Kirsch RE; Kew MC; Aspinall S; Sims J S Afr Med J; 1996 Mar; 86(3):245-51. PubMed ID: 8658294 [No Abstract] [Full Text] [Related]
8. [Post-transfusion hepatitis]. Koga M; Yano M Nihon Rinsho; 1988 Dec; 46(12):2579-83. PubMed ID: 2853796 [No Abstract] [Full Text] [Related]
9. [Clinical and epidemiological study of post-transfusion hepatitis]. Tateda A; Kikuchi K Rinsho Byori; 1984 Nov; 32(11):1194-201. PubMed ID: 6441039 [No Abstract] [Full Text] [Related]
11. [Present status of transfusion-associated hepatitis C virus infection and efficiency after implementation of nucleic acid amplification testing]. Takahashi M; Uchida S Nihon Rinsho; 2011 May; 69 Suppl 4():114-21. PubMed ID: 22096904 [No Abstract] [Full Text] [Related]
12. [Administrative policy concerning the issue of hepatitis virus infection by blood products]. Kanai M Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):272-8. PubMed ID: 15359806 [No Abstract] [Full Text] [Related]
13. [Route of transmission and prevention of non-A, non-B hepatitis]. Iino S Nihon Rinsho; 1988 Dec; 46(12):2729-34. PubMed ID: 3149346 [No Abstract] [Full Text] [Related]
14. Hepatitis C: the tracing dilemma. Jones AP; Meech RJ; Selderbeek H; Anderson B N Z Med J; 1993 Oct; 106(965):434-5. PubMed ID: 8414284 [No Abstract] [Full Text] [Related]
15. [Hepatitis C and hemophilia]. Aguilar C; Lucía JF Med Clin (Barc); 1995 Jun; 105(4):139-41. PubMed ID: 7623506 [No Abstract] [Full Text] [Related]
16. The risk of transfusion-transmitted infection. Dodd RY N Engl J Med; 1992 Aug; 327(6):419-21. PubMed ID: 1625717 [No Abstract] [Full Text] [Related]
17. Hepatitis C: the physician's responsibility? W V Med J; 1999; 95(3):114. PubMed ID: 10352568 [No Abstract] [Full Text] [Related]
18. [Risk of transfusion-transmitted infection in Japan]. Satake M Rinsho Ketsueki; 2014 Oct; 55(10):2152-61. PubMed ID: 25297782 [No Abstract] [Full Text] [Related]
19. [Blood-borne viral infection in hemodialysis units: special reference to hepatitis B virus, hepatitis C virus and human T-lymphotropic virus type 1]. Washio M Nihon Koshu Eisei Zasshi; 1998 Oct; 45(10):960-7. PubMed ID: 9893464 [TBL] [Abstract][Full Text] [Related]
20. HCV infection in blood donors. James V Br J Hosp Med; 1994 Nov 16-Dec 13; 52(10):541. PubMed ID: 7858808 [No Abstract] [Full Text] [Related] [Next] [New Search]